Provider Guide: Helping Your Patients Save Money on Ozempic

The bottom line for prescribers: Ozempic is clinically effective but financially out of reach for many patients without the right support. This guide walks you through the practical tools at your disposal — from manufacturer savings programs and prior authorization strategy to formulary navigation and pharmacy-level price variation — so your patients can stay on therapy without breaking the bank.

---

Cost is one of the most common reasons patients abandon GLP-1 therapy. A patient who fills their first Ozempic prescription, experiences real benefit, and then quietly disappears from your practice three months later often isn't non-compliant by choice — they simply can't sustain a $900/month out-of-pocket cost.

As a prescriber, you have more leverage over this problem than you might think. Understanding the financial landscape around Ozempic — and knowing which tools to reach for — can be the difference between a patient who stays on therapy and one who stops.

---

Understanding the Real Cost Burden

Before you can help, it's worth understanding what your patients are actually paying.

Without insurance: The list price of Ozempic is approximately $935–$1,000 per month for a 0.5 mg or 1 mg maintenance dose. That's before any discounts, coupons, or assistance programs.

With commercial insurance: Costs vary enormously. Patients with formulary coverage and a good copay tier may pay as little as $25–$50/month. Patients whose plans classify Ozempic as non-preferred, or whose plans have high deductibles, may still face several hundred dollars per fill even with "coverage."

With Medicare Part D: Here's where it gets harder. The Novo Nordisk savings card (see below) is not available to Medicare, Medicaid, or government-funded insurance patients. For Medicare beneficiaries, Ozempic coverage depends entirely on their specific Part D plan. Many pay $200–$500/month in the coverage gap. Starting in 2025, the Inflation Reduction Act caps out-of-pocket costs for Part D enrollees at $2,000 annually, which provides some relief — but doesn't eliminate the burden in the first half of the year.

The coverage mismatch problem: Ozempic is FDA-approved for type 2 diabetes management. When it's prescribed for weight loss (a use case for which Wegovy — the higher-dose semaglutide — is the approved option), many insurers will deny coverage entirely. This distinction matters enormously for prior authorization and reimbursement, and we'll come back to it.

---

The Novo Nordisk Savings Card: How It Works and Who Qualifies

Novo Nordisk offers a savings card program for commercially insured patients that can reduce the monthly cost of Ozempic to as low as $25/month (with a maximum savings cap per fill that varies by program year — confirm current terms at novonordisk-us.com).

Key eligibility rules:

• Must have commercial or private insurance that covers Ozempic
• Not eligible for patients using Medicare, Medicaid, CHIP, or any federal/state government insurance program
• Patients must be US residents

How to direct patients: Patients can enroll at the Novo Nordisk savings card website or through the pharmacy directly. It's worth noting in your care plan documentation, or having your MA flag this for eligible patients at checkout.

For patients who don't qualify — particularly Medicare beneficiaries — other strategies become more important.

---

Patient Assistance Programs for Uninsured and Underinsured Patients

If your patient is uninsured or underinsured and doesn't qualify for the commercial savings card, the Novo Nordisk Patient Assistance Program (PAP) may be the next best option.

The PAP provides free Ozempic to qualifying patients based on income thresholds (generally up to 400% of the federal poverty level, though this can change — verify current criteria at novonordisk-us.com/pap or through NeedyMeds.org).

Practical steps for your office:

• Have your care coordinator or social worker help with PAP enrollment — the application process requires prescriber signature and income documentation
• NeedyMeds.org and RxAssist.org are reliable databases for verifying current PAP eligibility and application forms
• Allow 4–6 weeks for initial PAP approval; bridge with samples if available

State pharmaceutical assistance programs (SPAPs) can also supplement costs for Medicare patients in certain states. It's worth knowing whether your state offers one.

---

Prior Authorization: Strategy Matters

Prior authorization is one of the highest-leverage points in your workflow for getting Ozempic covered — and one of the most frustrating when handled reactively.

Be proactive about step therapy documentation. Most plans that require prior authorization for Ozempic will want evidence that the patient has tried (and failed, or has a contraindication to) metformin and at least one other oral agent. Make sure your documentation clearly reflects:

• Current HbA1c and trend over time
• Prior medications tried, doses used, and reasons for discontinuation or inadequacy
• Cardiovascular risk factors (Ozempic has an FDA-approved cardiovascular outcomes indication — SUSTAIN-6 data — which can strengthen your medical necessity argument)
• Obesity and metabolic comorbidities that make glycemic control more complex

Invoke the cardiovascular outcomes data. Ozempic is FDA-approved to reduce the risk of major adverse cardiovascular events (MACE) in adults with type 2 diabetes and established cardiovascular disease. If your patient has atherosclerotic cardiovascular disease, documenting this indication explicitly in your PA request is often decisive.

Know when to appeal — and how fast. Denial is not the end. A well-documented peer-to-peer review request from you personally (rather than staff-initiated) succeeds at a meaningfully higher rate. Keep a template appeal letter that references clinical guidelines (ADA Standards of Medical Care) on hand. Most PA denials have a 30–60 day appeal window — don't let it lapse.

---

Formulary Navigation: Getting to the Right Tier

If your patient is newly insured or changing plans, you have a window to influence which medication they start on — and that affects cost for years.

Check the formulary before prescribing. Tools like CoverMyMeds, RxNavigator, or a quick call to your practice's billing team can identify whether Ozempic is on formulary for a patient's specific plan before you write the prescription. A few minutes here can save your patient hundreds of dollars a month.

Consider therapeutic alternatives when appropriate. Dulaglutide (Trulicity) and liraglutide (Victoza) are GLP-1 agonists that sit on preferred tiers on more formularies than Ozempic does. For patients who are earlier in their diabetes journey, cardiovascular risk profile permitting, a preferred GLP-1 may provide similar efficacy at dramatically lower cost. For a full comparison of available alternatives, see alternatives to Ozempic.

Formulary exception requests are available on most plans and are worth pursuing when Ozempic is clinically necessary but non-preferred. The documentation required mirrors a prior authorization — comorbidities, prior therapy, cardiovascular risk — and the approval rate improves significantly when the prescriber letter is specific and clinical rather than generic.

---

Pharmacy-Level Price Variation: More Than You'd Expect

Here's something many prescribers don't fully account for: the cash price of Ozempic — and even the insurance copay — can vary by $100–$300 depending on which pharmacy your patient uses, what discount programs are applied, and how the prescription is submitted.

GoodRx and discount card platforms can sometimes bring the cash price of Ozempic down to $800–$870, compared to the full list price at many chain pharmacies. This won't help uninsured patients reach affordability on its own, but it can close a meaningful gap in specific situations.

Big-box retailers (Walmart, Costco, Sam's Club) often have lower baseline dispensing costs and can offer better prices on some medications. Costco in particular is consistently among the lower-cost options for brand-name drugs. These prices are pharmacy-specific and vary by location.

Independent pharmacies can sometimes negotiate differently with wholesalers and may have more flexibility with pricing than large chains — though this varies widely.

The practical challenge: few patients have the time or bandwidth to call 10 pharmacies asking about price and stock. That's where a service like FindUrMeds can help — not just for shortage situations, but as a routine cost-and-access tool.

---

How FindUrMeds Helps With Both Access and Affordability

FindUrMeds is a pharmacy locator service that contacts pharmacies on behalf of patients to find their prescription in stock at a nearby location — usually within 24–48 hours, across 15,000+ locations nationwide including CVS, Walgreens, Rite Aid, Walmart, Kroger, Publix, Costco, and Sam's Club.

For Ozempic specifically, this addresses two compounding problems your patients often face simultaneously: shortage-driven stockouts and cost variation by pharmacy.

When a patient is willing to fill at the lowest-cost option in their area but doesn't know where to look — or when ongoing supply disruptions mean their usual pharmacy is out of stock — FindUrMeds does the legwork. Patients don't have to spend an afternoon on hold. You don't have to field follow-up calls about where to find the medication you just prescribed.

For guidance on the access side of this equation, see how to help patients find Ozempic in stock.

---

A Quick Reference Checklist for Your Practice

Use this at the point of prescribing or during care plan review:

• Check formulary tier before prescribing; consider preferred GLP-1 if appropriate
• Enroll eligible commercial insurance patients in the Novo Nordisk savings card
• Screen for PAP eligibility (uninsured, underinsured, income-qualifying patients)
• Document cardiovascular comorbidities, prior therapy, and HbA1c trend for PA requests
• Flag Medicare patients for SPAP programs in applicable states
• Advise patients to compare prices across pharmacy locations (or use FindUrMeds)
• Have a PA appeal template ready; conduct peer-to-peer reviews personally when possible

---

FAQ

Can my patient use GoodRx on Ozempic if they have insurance?

Generally, no — insurance and GoodRx/discount cards cannot be combined in the same transaction. In some cases, the GoodRx cash price may actually be lower than the insurance copay, particularly for patients with high-deductible plans or unfavorable tier placement. It's worth checking both and advising patients to use whichever is lower at a given pharmacy.

What's the difference between Ozempic's PAP and the savings card?

The savings card is for commercially insured patients and reduces the copay at the point of sale. The PAP is for uninsured or underinsured patients who meet income criteria — it provides the medication free of charge through a separate application process. Patients can't use both simultaneously, and Medicare patients are ineligible for the savings card but may qualify for the PAP.

How should I document a PA request if Ozempic is being used for its cardiovascular indication?

Explicitly state the ASCVD diagnosis in the PA letter and reference Ozempic's FDA approval for reducing MACE risk in adults with type 2 diabetes and established cardiovascular disease. Cite the SUSTAIN-6 trial outcomes data and ADA guidelines recommending GLP-1 agonists with proven cardiovascular benefit for high-risk patients. This reframes the request from a diabetes medication to a cardiovascular risk reduction therapy — which carries more weight with most payers.

Is there a generic version of Ozempic available?

No. As of 2025, there is no FDA-approved generic semaglutide. Compounded semaglutide has been widely available through compounding pharmacies during shortage periods, but the FDA removed semaglutide from its shortage list in early 2025 and has taken steps to restrict compounding of this drug. The clinical and legal status of compounded semaglutide is evolving — counsel patients carefully and verify current FDA guidance before recommending or endorsing any compounded version.

---

Need help finding Ozempic in stock? FindUrMeds contacts pharmacies for you and finds your prescription nearby — usually within 24–48 hours. No more calling around.

Find Ozempic Near You →

---

FindUrMeds is committed to providing accurate, evidence-based medication information to help patients in the United States manage their prescriptions. This content is for informational purposes only and does not constitute medical advice. Always consult your doctor or pharmacist before making any changes to your medication regimen.

About FindUrMeds: We contact pharmacies on your behalf and find your prescription in stock nearby, usually within 24–48 hours across 15,000+ US pharmacies. Learn how it works →